Biomimetic glyceride prodrugs facilitate targeted delivery to the lymphatics, lymph nodes and adipose tissue

• In: SUBMITTED ORALS on Tuesday, 15 April 2014, 16:00-17:30
• At: PSWC, Melbourne (Australia) (2014)
• Type: Presentation
• By: TREVASKIS, Natalie (Monash Institute of Pharmaceutical Sciences, Drug Delivery, Disposition and Dynamics, Parkville, Australia)
• Co-author(s): Loosli, Michaela (Monash Institute of Pharmaceutical Sciences, Parkville, Australia)
  Gracia, . (Monash Institute of Pharmaceutical Sciences, Parkville, Australia)
  Quach, Tim (Monash Institute of Pharmaceutical Sciences, Parkville, Australia)
  Simpson, Jamie (Monash Institute of Pharmaceutical Sciences, Parkville, Australia)
  Porter, Chris (Monash Institute of Pharmaceutical Sciences, Parkville, Australia)
  
• Abstract:

  Background: The lymphatics play essential roles in immunity, cancer metastasis and dietary triglyceride transport, and interact with surrounding adipose. Strategies to deliver therapeutics (such as aspirin (ASP) which is anti-inflammatory and influences lymph vessel contractility) and imaging agents to lymphatics and adipose could thus improve..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login